Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Fierce competition and threat of Trump tariffs lead to Danish company cutting costs

Sales of Novo Nordisk’s injectable diabetes drugs including Ozempic have slowed sharply amid fierce competition and …